chrisvoncsefalvay/vaers-outcomes huggingface dataset:
first dose of Shingrix on 22-Mar-2021 / second dose on 17-May-2021.; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 17th May 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 17th May 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: A pharmacist reported that a patient received the 1st dose of Shingrix on 22th March 2021 and the 2nd dose on 17th May 2021 that was less than recommended time interval and which led to shortening of vaccination schedule. The reporter consented to follow up.
Extreme shortness of breath rapide pulse; warm and sweaty; oxygen saturation = 100%; anxious
When doing regular upper body exercise routine,(abdominal crunch, lateral pulldown & chest press),  (normally 60lbs, 25 reps), had to reduce to 50 lbs, 15 reps.  Could not do the 60 pounds.  I've been doing these exercises weekly for at least past 5 years.
pt recv vax 20MAY96 & 2JUN96 rt knee swelling, rash all over, t101 x 3 days/cough, light sensitivity, h/a, sore throat;seen in ER but not contagious-measles?;5JUN96 rash cont w/other sx;seen in MD office 6JUN96;
Tachycardia, shortness of breath, and nausea with second dose of Pfizer-BioNTech COVID-19 vaccine 0.3 mL IM in left deltoid. vitals stable. Monitored in clinic for 1 hour and then sent to ED for further evaluation. ECG normal. Patient able to discharge in stable condition.
I had chapped lips which progressed to perioral dermatitis which was unresponsive to hydrocortisone cream, monostat, triamcinolone, vaseline. Sought PCP's direction and will be sent for consult to dermatologist.
per pt states that she had extreme pain in arm where she was injected, she claims she was "screaming in pain" all night, she also reports redness in the area and swelling
Initially, aches, chills, nausea, fatigue and acute headache on the top of eyes and across forehead; light sensitivity.  Other symptoms have resolved but headache and light sensitivity have persisted for 10 days as of today. Not relieved with Tylenol or Naproxen.
During the night of 5/9/21 I woke up because I wanted to turn over and could not move my arms or legs. I was able to move my head. I waited a bit, then tried to tell my limbs to move. Still could not move. After lying there for a while I was able to turn over with exertion.  The next day and for months after, I had generalized stiffness which I had never experienced before. I had pain right elbow, not at injection site but 2-3 inches above and below right elbow. I had weakness in right arm with difficulty lifting or using right arm in the usual manner.  I initially went to pharmacist that gave me the injection. He blew me off.
Patient c/o dizziness  immediately after receiving the vaccine. She walked from the vaccine station to the waiting area and alerted staff that she felt dizzy. No SOB, no rash, no throat tightness.  She had a similar episode in October. Recently increased Lisinopril dose.  She was laid down on a stretcher. Vitals were stable. Glucose=105. Transported to ER for further work-up.  Dizziness resolved prior to transport.
LEFT BELLS PALSY 2/5/2023 CHRONIC OR UNS GASTRIC ULCER W/HEMORRHAGE
pt recvd vax & devel lymphadenopathy & a fever; pt complained of aching in the deltoid region;
101 degree temperature  Chills and sweating  Severe soreness at injection site  Lethargy
This spontaneous report as received from a Vaccine for Children (VFC) coordinator refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with improperly stored doses of GARDASIL 9 lot # M037770, expiration date 01-JUN-2019 (dose and route of administration were not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 9 to 25 degrees Celsius for 36 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information is not expected because there was no consent for further contact. Sender's Comments: US-009507513-1704USA000270.
slight headache about hour after vaccination and lasted for several hours.  Nausea started the 2nd night post vaccine with abdominal cramping/diarrhea starting the following morning. Fatigue and slight weakness also noted.
Abrupt severe headache and nausea, with moderate dizziness, fatigue, light headed, and chills started 5/14 at 1:30 pm. Took ibuprofen at 2pm.  Symptoms eased up but not completely gone at 3pm. Severe nausea, fatigue, dizziness at 4pm. Headache intensifies at 7. Ibuprofen taken at 7:15. Moderate headache, nausea, dizziness and fatigue as of now, 8:15
5-10-16 seizure, taken to ED via ambulance, admitted to ICU. Inpatient for approx. 48 hrs, discharged to home. Unknown etiology for seizure activity. Currently on KEPPRA until 2 yr of age. Dx prolonged seizure in a 4 mo previously healthy, developmentally normal female.
Mild pain right hip comes and goes. After 2nd  booster reactivated shingles, arthritis pain getting worse. After 3rd booster shingles every month and arthritis pain in right hip has gotten bad.  Pfizer 3/4/2021, Pfizer 10/28/2021 Pharmacy, Pfizer 4/5/2022 Pharmacy, Pfizer 9/7/2022 Pharmacy
pt recv vax & exp pain in lower par of hand & in lower par of lt arm swelling of hand, & hand & arm were blue & cold;pt still had an ache in hand & hand still swollen;exp shooting pain down lt arm;hand felt numb, hard to move, & weird;red;
Chills, fever (100.8), bodily aches and pains, headache, dizziness, loss of consciousness, extreme fatigue, weakness. Pain and fever lasted for 3 days. Anxiety regarding increased risk of Guillain-Barre and fear of being alone and losing consciousness and falling. Anxiety about having to delay or decline Covid vaccine booster and seasonal flu shot.
Acute myocarditis; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Mar-2022 and was forwarded to Moderna on 16-Mar-2022.    This literature-non-study case was reported in a literature article and describes the occurrence of MYOCARDITIS (Acute myocarditis) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (Acute myocarditis) (seriousness criteria hospitalization and medically significant). At the time of the report, MYOCARDITIS (Acute myocarditis) outcome was unknown. Related      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered MYOCARDITIS (Acute myocarditis) to be related.    Concomitant and treatment medication information was not provided.  Company Comment: This literature non-study case concerns  a 19 year old male patient with no medical history reported , who experienced Serious ( hospitalization , medically significant ) , expected event of myocarditis. This event occurred on an unknown date after receiving  the 2nd dose of mRNA-1273 vaccine This patient was admitted because of acute chest pain. . The details surrounding this event were not reported since the full text of this literature for review is not available .The event outcome was unknown.. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report. The reviewer has limited information regarding this case as mentioned since the full text was not available at the time of the medical review.   This case was linked to MOD-2022-513579, MOD-2022-513580, MOD-2022-513581.; Sender's Comments: This literature non-study case concerns  a 19 year old male patient with no medical history reported , who experienced Serious ( hospitalization , medically significant ) , expected event of myocarditis. This event occurred on an unknown date after receiving  the 2nd dose of mRNA-1273 vaccine This patient was admitted because of acute chest pain. . The details surrounding this event were not reported since the full text of this literature for review is not available.The event outcome was unknown.. The benefit -risk relationship of mRNA -1273 ( Moderna Covid 19 Vaccine) is not affected by this report. The reviewer has limited information regarding this case as mentioned since the full text was not available at the time of the medical review.
23-SEP-89 pt received Engerix B & developed nausea followed by malaise a few days later which continues to date.  RUO pain started a few days after vaccination. Elevated LFTS and Bilirubinuria.
Patient fainted shortly after receiving the vaccine. He was only out for a short moment and then started talking again. He stated he felt woozy and then after a cold compress on his neck and some water he felt better. He also said that he hadn't eaten anything yet.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation, referring to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about September 2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for the long-term prevention of shingles and/or zoster-related conditions (strength, dose, route of administration, anatomical location, lot number, and expiration date were not reported). At the time of vaccination, the patient relied on the warning label affixed to zoster vaccine live (ZOSTAVAX), and the information relayed through the patient's healthcare provider that zoster vaccine live (ZOSTAVAX) was effective in preventing shingles on a permanent basis and did not carry any significant risk of adverse effects, which induced the patient to be vaccinated. Alternatively, on or about 2017, the patient's healthcare providers included but not limited to a healthcare provider, relied on the warning label affixed to the zoster vaccine live (ZOSTAVAX) vaccine, believed that it was effective in preventing shingles on a long-term or permanent basis that it did not carry any significant risks of adverse effects. On an unknown date, reported as subsequent to the vaccination, the patient was treated for shingles. As a direct and proximate result of the patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffered ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of shingles was not recovered. The reporter considered shingles to be related to zoster vaccine live (ZOSTAVAX).
pt recvd vax;48 hrs later,itchy arm at inject site;eyes & ha lasting over 72 hrs;as of 14-15nov all sxs gone;
Cortisone Injection In Knee; This spontaneous case was reported by a consumer and describes the occurrence of JOINT INJECTION (Cortisone Injection In Knee) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced JOINT INJECTION (Cortisone Injection In Knee). At the time of the report, JOINT INJECTION (Cortisone Injection In Knee) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
There are 5 published case reports on patients developing sarcoidosis in close time proximity to COVID-19 mRNA vaccination; This is a literature report.  A patient (no qualifiers provided) received bnt162b2 (COVID-19 VACCINE NOS MANUFACTURER UNKNOWN), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: SARCOIDOSIS (medically significant), outcome "unknown", described as "There are 5 published case reports on patients developing sarcoidosis in close time proximity to COVID-19 mRNA vaccination".; Sender's Comments: Based on the information provided in the narrative, a causal association between the event Sarcoidosis and the suspect drug cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-PV202300165539 same article/drug/event and different patient;US-PFIZER INC-202300319518 same article/drug/event and different patient;
I experienced blurred vision both eyes; like looking through fog.  I had  pain in my left eye
Arm soreness began. Arm warm to touch the next day and pain in arm and shoulder. I took Tylenol and site tenderness ended in a few days. However excruciating pain in shoulder and upper arm continued until present. I have to take some sort if pain medication daily but pain does not ever subside.
sxs of Shortness of breath and productive cough with green phlegm started on 9/05/2021. ADmitted to Hospital on 9/6/2021 and diagnosed with COVID pneumonis
Redness, swelling, and pain in right calf--symptoms increased throughout the day and remained for approximately 4 days before gradually decreasing over time.
One week after first shot in left arm, developed a large, itchy welt at injection site, accompanied by swollen lymph node under left arm.  Three weeks after shot, still have tender, swollen lymph node.
Patient began feeling nauseated on 1/18/21  around 6pm, and had uncontrolled diarrhea, reported that she did not feel right.  Staff reported to this writer, that her skin tone was gray in tone and she just didn't look good.  She was transferred to the HOSPITAL ER VIA AMBULANCE.
chest pain, fever, chills, nausea, vomiting diarrhea, myalgias and hematuria.  BP 170-195/76-89, BMI 30.3 kidney biopsy received on 4/26/21 showed: MPO-ANCA+ anti-GBM associated crescentic GN; also has C3 glomerulopathy
3 Lipoma appeared on right side of body, rt arm; rt knee; rt ankle the day after my second dose of the Pfizer Covid Vaccine.
pt recv vax 12SEP95 & 13SEP95 pt devel a local rxn distal to the point of entry @ the inj site & extended from halfway down the humerus to the elbow, w/induration & swelling;MD visit;pt medical records  not an allergy to pneumococcal vax;
Pains in my left upper leg, my right foot, swelling of right index finger and back pain.
FELT LIKE GOING SENILE; SHORT TERM MEMORY LOSS; SWELLING; FATIGUE; This spontaneous report received from a consumer concerned a patient of unspecified age and sex and unknown race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced short term memory loss, swelling, felt like going senile, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the short term memory loss, fatigue, swelling and felt like going senile was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210754945.; Sender's Comments: V0.20210920395-covid-19 vaccine ad26.cov2.s -Senile dementia. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
received the 1st dose of Shingrix over a year ago; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose of Shingrix received over a year ago ).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The reporter stated that a patient received the 1st dose of Shingrix over a year before reporting and wanted to know if she should restart the series or get the 2nd dose at the time of reporting, which led to incomplete course of vaccination. The reporter did not provide initials of patient when asked and did not have the exact date of the first dose, stating that the patient did not get the 1st dose at their pharmacy.  The reporter requested to follow up via postal. The reporter consented to follow up.
An hour after the booster shot, I had chest pains and hives. I had this reaction last time. I told the pharmacist. She recommended that I take Benadryl if it happens again. This did help, but when I missed a dose over night I woke up with hives and chest pains again. The following day I had a fever, aches, chills, and nausea.
This was Johnson & Johnson Vaccine.  I had the normal symptoms but it still felt very severe. I think there should be emphasis shared that symptoms might be severe. I believe the public should have a clear idea how severe. From 7pm to 12am I experienced extreme temperature changes, burning hot to very cold. I had the shakes. Headache. I took Advil which helped endure.  Buried myself in blankets with heater and heat on.  Drowsy. Experienced some dizziness. Now 3 days later I have some 'pings' here and there but uncertain if from vaccine. I feel these in my ovaries and my legs and my side. These are very subtle 'pings' (bit of pain but not much). Unsure if worth reporting but I think all this is important. Also, I have anxiety about the effect on this vaccine on the health of women and think it is very important that this is clear before pushing people -- more specifically young women, girls, babies -- to take this, and perhaps, any vaccine. I have been told from 5 friends they experienced heavy bleeding after taking the vaccine. They may have not all taken the J&J vaccine to be clear.  I do not feel great about having taken this vaccine.  I feel like i've put myself at risk of some other complications but of course, this is based on news and fear.  I just wanted to share this experience, and I hope that, if anything, the severity of symptoms might be more broadly shared.
full dose instead of a half dose; Five doses of the Moderna Covid-19 Vaccine were given to patients today,; Five doses of the Moderna Covid-19 Vaccine were given to patients today,29Oct2021, after being in the refrigerator starting on 8Sep2021; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (full dose instead of a half dose), EXPIRED PRODUCT ADMINISTERED (Five doses of the Moderna Covid-19 Vaccine were given to patients today,) and PRODUCT STORAGE ERROR (Five doses of the Moderna Covid-19 Vaccine were given to patients today,29Oct2021, after being in the refrigerator starting on 8Sep2021) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A, 012A21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (full dose instead of a half dose), EXPIRED PRODUCT ADMINISTERED (Five doses of the Moderna Covid-19 Vaccine were given to patients today,) and PRODUCT STORAGE ERROR (Five doses of the Moderna Covid-19 Vaccine were given to patients today,29Oct2021, after being in the refrigerator starting on 8Sep2021). On 29-Oct-2021, ACCIDENTAL OVERDOSE (full dose instead of a half dose), EXPIRED PRODUCT ADMINISTERED (Five doses of the Moderna Covid-19 Vaccine were given to patients today,) and PRODUCT STORAGE ERROR (Five doses of the Moderna Covid-19 Vaccine were given to patients today,29Oct2021, after being in the refrigerator starting on 8Sep2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment drugs were reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Oct-2021: Contact information fax was updated and event added Product storage error.
Patient's mother falsefied DOB on consent form. Correct DOB of patient is unspecified (4 years old).  DOB provided on form by mother was unspecified. Patient was not eligible for vaccine due to age but received the first dose of pfizer as a 4 year old. Discovery of error was made while billing vaccine administration fee after vaccine given. Mother admitted to falsifying DOB on consent form. As of 3 hours after administration, no adverse events have occured.
Low Grad Temp Comes & Goes. Right Ear Tenderness Along Jaw Bone. Problems Result After Some Usage (Whether Talking, Chewing), Some Ear Ringing, Dizziness, and Cough.
Patient's wife called approx 4 hours after receiving vaccine. Patient developed rash on face/neck area. Patient was given BENADRYL.
EE developed tingling in left arm, tingling of tongue and roof of mouth, started feeling like her tongue/mouth was swelling.  Was given 50 mg of Benadryl PO at 1255. Symptoms continued to worsen, to Emergency Dept at 1300.  Was given IV solumedrol and Pepcid.  Oral Zyrtec and discharged home.  OK to RTW with out restrictions.  Upon f/u EE did report a hive like rash on the right side of her body but this has since resolved as well.
I tested positive for COVID-19 on September 18/2022. My main symptoms were stuffy nose, sore throat, headache, and high temp of 99. These symptoms lasted about a week. I reached out to my prescription and was prescribed propranolol for my headaches. As of now I am still having some long standing symptoms such as nausea, fatigue, and headaches and since coming down with COVID-19 I have been feeling this way.